Market Signal Briefing

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Beyond Meat, Inc. (NASDAQ: BYND) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Beyond Meat securities between February 27, 2025 and November 11, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/BYND.

Beyond Meat Case Details

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that:

 (1)the book value of certain of Beyond Meat's long-lived assets exceeded their fair value, making it highly likely that the Company would be required to record a material, non-cash impairment charge; (2)the foregoing was likely to impair Beyond Meat's ability to timely file its periodic filings with the U.S. Securities and Exchange Commission ("SEC"); and (3)as a result, Defendants' public statements were materially false and misleading at all relevant times.    What's Next for Beyond Meat Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/BYND. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Beyond Meat you have until March 24, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Beyond Meat Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Beyond Meat Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Enphase Energy, Inc. (NASDAQ: ENPH) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Enphase securities between April 22, 2025 and October 28, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/ENPH.

Enphase Case Details

The Complaint alleges that throughout the class period, Defendants failed to disclose that:

(1) Enphase overstated its ability to manage its channel inventory; 
(2) Enphase overstated its ability to mitigate effects arising from the termination of the 25D Credit (which allowed homeowners to deduct 30% of costs of clean energy property they install at their homes) on December 31, 2025 instead of December 21, 2032; and 
(3) accordingly, Enphase overstated its financial and operational prospects.

What's Next for Enphase Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/ENPH. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Enphase you have until April 20, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Enphase Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Enphase Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]

Attorney advertising.
Prior results do not guarantee similar outcomes.

LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced it has been informed that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, has acquired 10,119 of the Company’s ordinary shares on NASDAQ at $1.59, bringing his total holding to 10,526,416 shares.

About Urcosimod (formerly called OK-101)

Urcosimod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor which is typically found on immune cells of the eye responsible for the inflammatory response, as well as on neurons and glial cells in the dorsal root ganglion. Urcosimod has been shown to produce anti-inflammatory and pain-reducing activities in a mouse model of dry eye disease and in a neuropathic corneal pain mouse model, respectively. OKYO recently announced positive data on NCP pain reduction in a randomized, placebo-controlled, double-masked Phase 2a trial involving 18 neuropathic corneal pain subjects. Urcosimod has shown significant pain reduction in an earlier 240 subject Phase 2, multi-center, double-masked, placebo-controlled trial in DED, which supports the development rationale in NCP.

About OKYO Pharma

OKYO Pharma Limited (Nasdaq: OKYO) is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP) and inflammatory eye diseases, with ordinary shares listed for trading on the Nasdaq Capital Market. OKYO is focused on the discovery and development of novel molecules to treat neuropathic corneal pain and other ocular diseases. OKYO recently completed a successful phase 2 trial of its flagship drug urcosimod in subjects with NCP and plans to initiate a ~150 subject Phase 2b/3 multiple-dose study of urcosimod to treat NCP in the first half of this year.

For further information, please visit www.okyopharma.com.

Inquiries:

Business Development & Investor RelationsPaul Spencer+44 (0)20 7495 2379

Stifel Financial NYSE: SF recently finished one of its strongest years ever and then split its stock. Clearly, the company feels optimistic. But the question is, should shareholders?

Maybe not a household name, but Stifel is making money by catering to households, institutions, and others. Managing client investments and advising companies on deals and in the capital markets, the company is doing more business with more clients. That’s partly thanks to last year’s rebound on Wall Street activity, but also from investors moving more of their money to Stifel.

Get Stifel Financial alerts:

Stifel's Growing Revenue and Operating Results To recap growth at Stifel: net revenue rose about 11% to a record $5.53 billion last year, the first time it climbed above $5 billion in the company’s 135-year history. The company then split its stock and raised its dividend. Overall, Stifel reported net income of $646.5 million with earnings per share (EPS) at $5.87.

Stifel Financial Today

SF

Stifel Financial

$70.01 -0.14 (-0.19%)

As of 12:06 PM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$48.85▼

$89.83Dividend Yield1.94%

P/E Ratio17.87

Price Target$90.13

Although EPS declined from 2024, the numbers don't reflect a slowdown in business. The net figure includes a $180 million legal expense taken in last year’s first quarter stemming from a FINRA case involving a former broker and client. The company says it’s appealing the ruling. Operationally, Stifel delivered earnings per share of $7.92 with a pre-tax margin of 21%, the company’s CEO said during an earnings call.

Further, as of the fourth quarter, Stifel showed it was putting shareholder money to good use, with its adjusted return on tangible common equity coming in at a very strong 31.1%.

The wealth‑management arm of Stifel is the steady, recurring part of its story. At the end of 2025, client assets reached $552 billion, up 10% from a year earlier, reflecting both market gains and money coming in. Within that, fee‑based assets rose 16% to $224.5 billion dollars. Net revenue at the unit rose 8% to $3.54 billion. The company’s investment banking unit saw revenue climb 26% to $1.2 billion.

Dividends Keep Going Up Stifel Financial Stock Forecast Today12-Month Stock Price Forecast:
$90.13
29.08% Upside

Moderate Buy
Based on 11 Analyst Ratings

Current Price$69.83High Forecast$103.33Average Forecast$90.13Low Forecast$70.00Stifel Financial Stock Forecast Details

Stifel also has a habit of returning cash to shareholders. The company announced in January that it was raising its quarterly dividend 11% to 51 cents per share. It was its ninth consecutive annual raise. Along with that, the company announced a 3-for-2 stock split.

Beyond the impressive raw numbers, valuation is where investors' personal judgment comes into play. Recent data show Stifel trading at a trailing price‑to‑earnings ratio around 20 and offering a dividend yield under 2%.

Analysts on Wall Street are generally positive but not overly excited, which could mark an opportunity. The consensus rating on the stock is a Moderate Buy, with a small majority of analysts slating the shares as a Buy. The average 12‑month price target is around $90, with the highest target above $100.

This all points to expectations of a steady, reasonable upside rather than a quick jump in valuation, suggesting Stifel is viewed more as a long‑term play rather than a short‑term trade.

Market Risks Are Obvious But when you play the market with a stock that’s dependent on the market, there’s always risk. Stifel’s investment‑banking business got a lift in 2025 as companies returned to the capital markets for deals and financing. But that activity can dry up quickly if the economy slows or stocks sell off, which would hit fee revenue and profits.

Stifel also runs a sizeable $32 billion bank, and like any lender, it faces credit risk if borrowers run into trouble.

Competition is another ongoing challenge. Stifel has to win advisors and clients from much larger players in the broader sector, such as Morgan Stanley NYSE: MS and Raymond James Financial NYSE: RJF, which have deep pockets and strong technology platforms.

A Competitive Future With Potential To keep up and keep growing, Stifel will need to keep investing in its systems, digital tools, and people. Those investments can squeeze profit margins if revenue growth slows. The trade‑off is clear: the company can keep gaining share in attractive markets, but it may need to spend aggressively to stay competitive.

Still, if market activity continues and wealth management keeps the appeal it now has, Stifel should benefit nicely. The company brings together a growing wealth‑management and advisory franchise, strong profitability metrics, a dividend that has been rising for years, and a new stock split. That will make the shares more accessible, all at a valuation that looks reasonable rather than stretched.

The business is tied to markets and deal activity, so expect more ups and downs than you would get from a utility or consumer staples stock. For patient investors building a diversified portfolio of financials, though, Stifel looks like a good candidate to buy on market pullbacks and then hold through the typical market cycles.

Should You Invest $1,000 in Stifel Financial Right Now?Before you consider Stifel Financial, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stifel Financial wasn't on the list.

While Stifel Financial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom. Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

6.79K Followers

Analyst’s Disclosure: I/we have a beneficial long position in the shares of AVAV either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

37.61K Followers

Analyst’s Disclosure: I/we have a beneficial short position in the shares of MU either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another.

Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a technical analyst for Dow Jones Newswires and as the senior market analyst with TraderPlanet.com. Jim is also a consultant with the highly respected "Pro Farmer" agricultural advisory service. Jim was also the head equities analyst at CapitalistEdge.com. He received his degree from Iowa State University in Ames, Iowa, where he studied journalism and economics.

Follow Jim daily on Kitco.com as he provides both AM and PM roundups and a daily Technical Special. 1 877 963-NEWS jwyckoff at kitco.com

Average weight loss of ~21% at 72 weeks in adults with obesity if all patients stayed on treatment* with Wegovy® HD (~19% regardless of whether patients stayed on treatment**) in the STEP UP trial1 In the STEP UP trial, about one in three trial participants taking Wegovy® HD achieved 25% weight loss or higher1 This approval for Wegovy® further expands its already robust label inclusive of multiple formulations, including Wegovy® pill, and indications not available with other GLP-1 weight loss medicines , /PRNewswire/ -- Novo Nordisk today announced US Food and Drug Administration (FDA) approval of a new higher dose of Wegovy®, Wegovy® HD (semaglutide) injection 7.2 mg, which demonstrated substantial weight loss in adults with obesity in the STEP UP trial.1,2 Wegovy® HD can be used along with a reduced calorie diet and increased physical activity to help adults with obesity lose weight and keep it off, provided they have tolerated the 2.4 mg dosage for at least 4 weeks and additional weight reduction is clinically indicated. This new update supplements the existing Wegovy® label, which also has distinct indications for Wegovy® not offered by any other GLP-1 medication for weight loss.2

Wegovy® HD (semaglutide) injection 7.2 mg "We are excited to bring Wegovy® HD injection to adults with obesity who are looking for powerful weight loss, as no other weight loss medicine has been studied to show superiority to Wegovy® HD," said Jamey Millar, executive vice president, US Operations of Novo Nordisk. "In addition to significant weight loss, Wegovy® is the only GLP-1 for adults with obesity that is proven to reduce the risk of events such as stroke, heart attack, or cardiovascular death in those who also have known heart disease. Today's milestone expands the strong clinical profile of Wegovy® that includes multiple indications that no other GLP-1 for weight loss can claim."

Prior to this approval, the highest approved dose of Wegovy® injectable for weight loss was 2.4 mg, which is also indicated, along with a reduced calorie diet and increased physical activity, to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.2

The FDA approval of Wegovy® HD is based on the results of the STEP UP trial program, which included STEP UP, a 72-week study which evaluated the efficacy and safety of once-weekly Wegovy® 7.2 mg compared to placebo and Wegovy® 2.4 mg, as an adjunct to lifestyle intervention in 1,407 adults with obesity (BMI 30 kg/m2 or greater), without diabetes.1,3

STEP UP Trial Results (at 72 weeks1, 2)

Wegovy® injection  
7.2 mg

Wegovy® injection
2.4 mg

Placebo

Average
weight
reduction1

If all patients stayed
on treatment

(Efficacy 
estimand*)

~21% (20.7%)

~18% (17.5%)

~2% (2.4%)

Analysis of all
patients regardless
of whether they
stayed on treatment2

(Treatment regimen
estimand**)

~19% (18.8%)

~16% (15.5%)

~4% (3.9%)

Percent of patients
who achieved 25% or
more weight loss**

31.2 %

15.3 %

0 %

Based on a mean baseline body weight of 248 lb. for Wegovy® injection 7.2 mg and placebo groups, and 257 lb. for the Wegovy® 2.4 mg group.

The most common adverse reactions reported with Wegovy® HD were nausea, vomiting, dysesthesia, constipation, abdominal pain, fatigue, headache, dizziness, hair loss and flatulence. In clinical trials, dysesthesia was reported at a higher rate with Wegovy® HD compared to Wegovy® 2.4 mg and placebo.2 Events related to a clinical picture of altered skin sensation such as sensitive skin, hyperesthesia, dysesthesia and paresthesia were reported by a higher proportion of participants, and at a higher rate, in the Wegovy® HD arm (22%), compared to treatment with Wegovy® 2.4 mg (6%) and placebo (0.3%).2

"Wegovy® HD represents an important new tool in obesity management, allowing clinicians to better tailor treatment strategies and help improve outcomes," said W. Timothy Garvey, MD, professor of medicine and director of the Diabetes Research Center at the University of Alabama at Birmingham. "The weight loss demonstrated with Wegovy® HD could reshape healthcare professionals' expectations about what outcomes are possible for their patients with Wegovy®."

Wegovy® HD will be available in April through all channels where patients can access Wegovy® including 70,000 plus pharmacies in the US like CVS and Costco, select telehealth providers, NovoCare® Pharmacy, GoodRx, and others. Additional information on coverage and savings options for eligible patients, including other programs designed to help reduce out-of-pocket costs, will also be available at that time.

* Based on the efficacy estimand: estimated efficacy in an idealized scenario in which all patients stayed on treatment and took no other weight loss therapies.
** Based on the treatment regimen estimand: treatment effect regardless of whether patients stayed on treatment or took other weight loss therapies.

About the STEP UP trial
STEP UP was a phase 3b 72-week randomized, double-blinded, placebo-controlled and active-controlled superiority trial designed to evaluate the efficacy and safety of semaglutide injection 7.2 mg compared to semaglutide injection 2.4 mg and placebo as an adjunct to lifestyle intervention.1 1,407 adults with BMI ≥30 kg/m2 without diabetes were included in the trial. The primary objective was to demonstrate superiority of semaglutide 7.2 mg against placebo on weight loss after 72 weeks with respect to the percentage change in body weight and the proportion of participants achieving weight loss of 5% or greater.1 Select confirmatory secondary endpoints included number of participants achieving ≥10%, 15%, 20% and 25% weight loss, with semaglutide 7.2 mg vs placebo (and for greater than or equal to 20% and 25%, semaglutide 7.2 mg vs semaglutide 2.4 mg).1 In total, 1,407 participants were randomized in a 5:1:1 ratio to receive once-weekly subcutaneous semaglutide 7.2 mg, 2.4 mg, or placebo, alongside lifestyle intervention, for 72 weeks.1 For those taking Wegovy® HD, 89% achieved 5% or greater body weight loss versus 38% taking placebo (from a baseline body weight of 248 lb.).**

About obesity 
Obesity is a serious, chronic, progressive, and complex disease that requires long-term management.4-6 One key misunderstanding is that this is a disease of just lack of willpower, when in fact there is underlying biology that may impede people with obesity from losing weight and keeping it off.4,6 Obesity is influenced by a variety of factors, including genetics, social determinants of health, and the environment.7,8

What is Wegovy®?

Wegovy® (semaglutide) injection is a prescription medicine used with a reduced-calorie diet and increased physical activity to:

reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight. help adults and children aged 12 years and older with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off. Wegovy® (semaglutide) tablets are a prescription medicine used with a reduced-calorie diet and increased physical activity to:

reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight. help adults with obesity, or some adults with excess weight (overweight) who also have weight-related medical problems to lose weight and keep the weight off. Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.

It is not known if Wegovy® injection is safe and effective:

to reduce the risk of major cardiovascular events (death, heart attack, or stroke) in people under 18 years to help children under 12 years of age lose weight and keep the weight off It is not known if Wegovy® tablets are safe and effective for use in people under 18 years of age.

Important Safety Information

What is the most important information I should know about Wegovy®?
Wegovy® may cause serious side effects, including:

Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer. In studies with rodents, Wegovy® and other medicines that work like Wegovy® caused thyroid tumors, including thyroid cancer. It is not known if Wegovy® will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people Do not use Wegovy® if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Do not use Wegovy® if:

you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy® injection or Wegovy® tablets.  See symptoms of serious allergic reaction in "What are the possible side effects of Wegovy®?" Before using Wegovy®, tell your healthcare provider if you have any other medical conditions, including if you:

have or have had problems with your pancreas or kidneys have type 2 diabetes and a history of diabetic retinopathy are scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation) are pregnant or plan to become pregnant. Wegovy® may harm your unborn baby. You should stop using Wegovy® 2 months before you plan to become pregnant are breastfeeding or plan to breastfeed. Breastfeeding is not recommended during treatment with Wegovy® tablets. It is not known if Wegovy® when received through an injection passes into your breast milk Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Wegovy® may affect the way some medicines work and some medicines may affect the way Wegovy® works. Tell your healthcare provider if you are taking other medicines to treat diabetes, including sulfonylureas or insulin. Wegovy® slows stomach emptying and can affect medicines that need to pass through the stomach quickly.

What are the possible side effects of Wegovy®?
Wegovy® may cause serious side effects, including:

inflammation of your pancreas (pancreatitis). Stop using Wegovy® and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel the pain from your abdomen to your back gallbladder problems. Wegovy® may cause gallbladder problems, including gallstones. Some gallstones may need surgery. Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay-colored stools increased risk of low blood sugar (hypoglycemia), especially those who also take medicines for diabetes such as insulin or sulfonylureas. This can be a serious side effect. Talk to your healthcare provider about how to recognize and treat low blood sugar and check your blood sugar before you start and while you take Wegovy®. Signs and symptoms of low blood sugar may include dizziness or light-headedness, blurred vision, anxiety, irritability or mood changes, sweating, slurred speech, hunger, confusion or drowsiness, shakiness, weakness, headache, fast heartbeat, or feeling jittery dehydration leading to kidney problems. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away severe stomach problems. Stomach problems, sometimes severe, have been reported in people who use Wegovy®. Tell your healthcare provider if you have stomach problems that are severe or will not go away serious allergic reactions. Stop using Wegovy® and get medical help right away, if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat change in vision in people with type 2 diabetes. Tell your healthcare provider if you have changes in vision during treatment with Wegovy® increased heart rate. Wegovy® can increase your heart rate while you are at rest. Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation). Wegovy® may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking Wegovy® before you are scheduled to have surgery or other procedures The most common side effects of Wegovy® may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, changes in skin sensations, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, and hair loss.

Please click here for Prescribing Information including Boxed Warning and Medication Guide for Wegovy®. 

About Novo Nordisk
Novo Nordisk is a leading global health care company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years. This heritage has given us experience and capabilities that also enable us to drive change to help people defeat other serious chronic diseases such as obesity, rare blood, and endocrine disorders. We remain steadfast in our conviction that the formula for lasting success is to stay focused, think long-term, and do business in a financially, socially, and environmentally responsible way. With a US presence spanning 40 years, Novo Nordisk US is headquartered in New Jersey and employs approximately 10,000 people across more than 10 manufacturing, R&D and corporate locations in eight states plus Washington, D.C. For more information, visit novonordisk-us.com, Facebook, Instagram, and X.

Contacts for further information

Media:

Liz Skrbkova (US)
+1 609 917 0632

[email protected]

Ambre James-Brown (Global)
+45 3079 9289
[email protected]

Investors:

Frederik Taylor Pitter (US)

+1 609 613 0568
[email protected]

Jacob Martin Wiborg Rode (Global)
+45 3075 5956
[email protected]

Sina Meyer (Global)

+45 3079 6656
[email protected]

Christoffer Sho Togo Tullin (Global)
+45 3079 1471

[email protected]

Max Ung (Global)
+45 3077 6414
[email protected]

Alex Bruce (Global)

+45 34 44 26 13
[email protected]

References:

Wharton S, Freitas P, Hjelmesæth J, et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial. Lancet Diabetes Endocrinol. 2025;13(11):949-963. Wegovy® (semaglutide) Prescribing Information. Plainsboro, NJ: Novo Nordisk Inc. Lingvay I, Bergenheim S, Buse J, et al. Once-weekly semaglutide 7.2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial. Lancet Diabetes Endocrinol. 2025;13(11):935-948. Kaplan LM, Golden A, Jinnett K, et al. Perceptions of barriers to effective obesity care: results from the national action study. Obesity. 2018;26(1):61–69. Bray GA, Kim KK, Wilding JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–723. Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22 (Suppl 3):1–203. Centers for Disease Control and Prevention. Adult obesity facts. Last accessed: March 2026. Available at: https://www.cdc.gov/obesity/adult-obesity-facts/index.html Centers for Disease Control and Prevention. Risk Factors for Obesity. Last accessed: March 2026. Available at: https://www.cdc.gov/obesity/risk-factors/risk-factors.html. © 2026 Novo Nordisk All rights reserved. US26SEMO00066 March 2026

SOURCE NOVO NORDISK INC.

Key Takeaways Carter's Retail sales rose 9% with comps up 4.7%, driven by strong e-commerce traffic.CRI faces margin pressure from tariffs and higher product costs despite pricing actions.Carter's expects 2026 sales growth in low to mid-single digits and plans store closures to boost efficiency. Carter’s, Inc. (CRI - Free Report) witnessed a strong performance in the U.S. Retail segment in the fourth quarter of 2025. Growth was fueled by robust e-commerce performance, supported by a double-digit increase in traffic. Retail segment delivered net sales growth of 9%, with comparable sales up 4.7%, marking the third straight quarter of gains. Strength was broad-based across Baby, Toddler and Kid categories, with all apparel brands contributing positive comp sales. Baby remained the standout segment, achieving its sixth consecutive quarter of growth and reinforcing its importance within the overall product portfolio.

However, the U.S. Retail segment's profitability declined in the quarter due to higher product costs, driven by tariff pressures and increased investment in products. These impacts were partially offset by higher pricing, which helped mitigate but did not fully absorb the overall cost increases. The company anticipates offsetting increased product costs through higher prices, especially in the retail segment, as well as supply chain mitigation and productivity initiatives.

For 2026, the company expects solid top-line and adjusted operating income growth, with net sales rising in the low to mid-single digits compared with 2025, factoring in the impact of the extra week. Growth is projected across all segments, including low single-digit gains in the U.S. Retail segment, with mid-single-digit comp growth. The company expects mid-single-digit growth in the U.S. Wholesale segment, driven by broad customer demand. Consolidated average unit retail (AUR) is expected to increase in the mid-single digits for 2026.

Additionally, Carter’s is driving productivity to offset cost pressures by closing around 60 lower-margin stores in 2026. It is also simplifying operations by reducing product choices by 20–30% and accelerating its product development cycle by three months to improve efficiency and responsiveness. Overall, strong retail momentum, pricing actions and productivity initiatives will help the company to offset tariff pressures in 2026.

The Zacks Rundown for CRICRI’s shares have gained 16.9% in the past six-month period against the industry’s decline of 21.9%. The company currently sports a Zacks Rank #1 (Strong Buy).

Image Source: Zacks Investment Research

From a valuation standpoint, CRI trades at a forward price-to-earnings ratio of 11.64X, lower than the industry’s average of 22.05X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for CRI’s current fiscal year earnings implies a year-over-year decline of 24.2%, and the same for the next fiscal year earnings indicates a year-over-year growth of 17.7%.

Image Source: Zacks Investment Research

Other Stocks to ConsiderSome other top-ranked stocks have been discussed below:

Columbia Sportswear Company (COLM - Free Report) engages in the design, development, marketing, and distribution of outdoor, active, and lifestyle products in the United States, Latin America, the Asia Pacific, Europe, the Middle East, Africa, and Canada. At present, COLM flaunts a Zacks Rank of 1. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for COLM’s current fiscal-year sales implies growth of 2%, and the same for earnings indicates a decline of 6.2% from the year-ago figures. COLM delivered a trailing four-quarter earnings surprise of 25.2%, on average.

Wolverine World Wide, Inc. (WWW - Free Report) designs, manufactures, sources, markets, licenses, and distributes footwear, apparel, and accessories. At present, WWW carries a Zacks Rank of 2 (Buy).

The Zacks Consensus Estimate for WWW’s current fiscal-year sales and earnings indicates growth of 5.5% and 9%, respectively, from the year-ago figures. WWW delivered a trailing four-quarter earnings surprise of 31.8%, on average.

Crocs, Inc. (CROX - Free Report) designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and kids. At present, CROX carries a Zacks Rank of 2.

The Zacks Consensus Estimate for CROX’s current fiscal-year sales and earnings implies growth of 0.4% and 7%, respectively, from the year-ago figures. CROX delivered a trailing four-quarter earnings surprise of 16.6%, on average.
 

Key Takeaways Oklo's nuclear model shows resilience amid geopolitical tensions and fossil fuel volatility.OKLO benefits from low fuel costs, enabling stable pricing despite global commodity swings.Oklo advances via licenses, fuel recycling and Centrus partnership to boost supply security. Oklo Inc.’s (OKLO - Free Report) nuclear energy model positions the company as a stable and resilient player amid rising geopolitical tensions. Disruptions such as the potential closure of the Strait of Hormuz — chokepoint for roughly 20% of the world’s petroleum and liquefied natural gas (LNG) trade — highlight the vulnerability of fossil fuel-dependent energy systems. As commodity prices surge during conflicts, natural gas-based power generation becomes increasingly volatile, directly impacting electricity costs.

In contrast, Oklo operates on a fundamentally different cost structure. While nuclear projects require higher upfront investment, their ongoing fuel costs are minimal and far less exposed to global market fluctuations. This allows Oklo to deliver more predictable and stable energy pricing, even during geopolitical instability.

The company’s strategic progress further strengthens its position. Recent regulatory approvals, including licenses from U.S. authorities for isotope handling and reactor development, are paving the way for initial commercial sales. Its advancements in fuel recycling, reactor design and isotope production diversify its capabilities and revenue potential. Additionally, partnerships with Centrus Energy to support nuclear fuel supply chains enhance long-term operational security.

Globally, nuclear energy is gaining renewed attention as countries seek reliable and secure power sources. With increasing commitments to expand nuclear capacity, Oklo stands to benefit from this structural shift.

Ultimately, as geopolitical risks disrupt traditional energy markets, Oklo’s nuclear approach offers a compelling solution — ensuring energy security, stabilizing electricity prices and reinforcing grid resilience in an uncertain world.

Other Nuclear Players Benefiting From the Nuclear Energy ModelNANO Nuclear Energy Inc. (NNE - Free Report) is a technology-focused firm aiming to build a commercially driven presence across portable microreactors, nuclear fuel fabrication and transport, and industry consulting. NNE recently reported progress in developing a proprietary transportation solution for High-Assay Low-Enriched Uranium, utilizing its exclusively licensed fuel transport basket design. This initiative aligns with NNE’s broader strategy to create vertically integrated capabilities across the nuclear supply chain, strengthening operational resilience and positioning the company to better withstand geopolitical uncertainties.

NuScale Power Corporation (SMR - Free Report) specializes in advanced small modular reactor technology designed to deliver clean, scalable power for data centers and AI applications, independent of traditional grids. The company holds a distinct advantage in the SMR market as the only U.S. player with multiple Nuclear Regulatory Commission-approved designs, overcoming a key regulatory barrier. This positions NuScale to accelerate commercialization while offering a reliable pathway to navigate ongoing uncertainties in the global energy landscape.

The Zacks Rundown on OKLOShares of Oklo have soared more than 104% over the past year, breezing past the industry's growth of 53.8%.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for OKLO’s 2026 earnings is pegged at a loss of 65 cents per share, indicating a 9.7% year-over-year improvement.

Image Source: Zacks Investment Research

See how the Zacks Consensus Estimate for OKLO’s earnings has been revised over the past 90 days.

Image Source: Zacks Investment Research

The stock currently carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Delta Air Lines CEO Ed Bastian tore into Congress for forcing airport security agents to work without pay, calling the situation “inexcusable” and accusing lawmakers of using frontline workers as “political chips” while a partial government shutdown drags into its fifth week.

“It’s inexcusable that our security agents, our frontline agents, that are essential to what we do, are not being paid, and it’s ridiculous to see them being used as political chips,” Bastian told CNBC on Tuesday.

“We’re outraged.”

The airline boss said Delta is already seeing the impact, with staffing shortages at security checkpoints fueling longer lines and delays at major hubs — including Atlanta, where extended wait times flared over the weekend.

Delta Air Lines CEO Ed Bastian blasted Congress for forcing TSA agents to work without pay, calling the situation “inexcusable.” CNBC “We certainly are [seeing it],” Bastian said, noting the disruptions tend to hit hardest on weekends.

He said weather worsened the situation but stressed the underlying issue is unpaid workers.

The standoff in Washington has left about 50,000 Transportation Security Administration officers working without pay since mid-February after lawmakers failed to fund the Department of Homeland Security.

Last week, Senate Democrats blocked a bill that would restore funding to DHS for the fourth time in the past month as more than 5,000 flights were delayed and 500 others were cancelled.

Despite being deemed essential, those workers have now missed at least one paycheck and will not be compensated until Congress reaches a deal.

Airport security lines swell as unpaid TSA officers continue working during the partial government shutdown. AFP via Getty Images The financial strain is already rippling through the workforce.

Call-out rates have more than doubled, and at least 300 TSA officers have reportedly quit since the shutdown began.

Many remaining agents are struggling to cover basic expenses such as rent, car payments and childcare.

The staffing crunch has spilled into airports nationwide.

Some checkpoints have been shut entirely, forcing travelers into fewer lines and triggering wait times lasting two to three hours — and in some cases even longer — at major airports including Atlanta, Houston and New Orleans.

Airlines have been scrambling to manage the disruption, holding flights for delayed passengers and rebooking others when possible.

“There’s been some [impact], we do our best to hold flights where we can. It’s not a massive issue,” Bastian told CNBC, downplaying the operational hit to Delta’s network.

He framed the crisis in terms of basic fairness.

“These people missed paychecks just a few months ago. They’re missing paychecks again. It’s outrageous,” he said.

Bastian’s remarks come as airline chiefs have been escalating pressure on Congress, warning that the situation is both unsustainable and avoidable.

TSA agents screen passengers as staffing shortages tied to the DHS shutdown trigger long lines and delays at airports nationwide. Luiz C. Ribeiro for NY Post In a March 15 open letter to lawmakers, the CEOs of major US airlines — including Delta, American, United, Southwest and JetBlue — urged immediate action to restore pay for federal aviation workers.

“There are very few issues upon which 9 out of 10 Americans agree,” the executives wrote, citing polling showing 93% of Americans support paying TSA workers during shutdowns.

People wait on a TSA line at the George Bush Intercontinental Airport in Houston on Wednesday, March 18, 2026. AP The letter warned that long security lines and delays will only worsen if agents continue working without pay, noting that Americans are “tired of long lines at airports, travel delays and flight cancellations caused by shutdown after shutdown.

“TSA officers just received $0 paychecks. That is simply unacceptable,” the CEOs wrote, adding that it is “difficult, if not impossible” for workers to afford basic necessities without income.

Long lines seen at O’Hare International Airport in Chicago on March 26, 2026. Anadolu via Getty Images The executives called on Congress to pass legislation that would guarantee pay for TSA officers, air traffic controllers and customs agents during future shutdowns — and to immediately fund DHS to end the current impasse.

The Post has sought comment from lawmakers.

, /PRNewswire/ -- First Horizon Bank (NYSE: FHN or "First Horizon") is proud to celebrate 25 years as the "Official Bank of Bristol Motor Speedway". Since 2001, the Memphis-based bank has been one of Bristol Motor Speedway's longest active sponsorship partners.

First Horizon and Bristol Motor Speedway logo "We take great pride in our 25-year relationship with the NASCAR racing legacy that is Bristol Motor Speedway," said Greg Perdue, Tri-Cities Market President for First Horizon. "Marking this key sponsorship milestone as the 'Official Bank of Bristol Motor Speedway' aligns with our commitment to investing in places that give people great experiences and serving our communities in unique ways that help grow our brand."

"At Bristol, the best partnerships feel like family traditions and First Horizon has earned that place here," said Jerry Caldwell, President and General Manager of Bristol Motor Speedway. "This 25th anniversary is a big moment for two Tennessee brands, and our shared values keep us moving forward together with the same focus on growth, service and community."

Race fans will notice the First Horizon brand is visible at strategic points around the Bristol Motor Speedway campus, including inside the world-famous oval in addition to designated exterior locations at the Entrance 3 Dragway marquee sign and on the Elevator E tower near Gates 6 and 7 at the oval. The bank also enhances the fan experience with a convenient ATM in the track's North Lot, at BMS Entrance #1 near the "It's Bristol, Baby" monument.

About First Horizon
First Horizon Corp. (NYSE: FHN), with $83.9 billion in assets as of December 31, 2025, is a leading regional financial services company, dedicated to helping our clients, communities and associates unlock their full potential with capital and counsel. Headquartered in Memphis, TN, the banking subsidiary First Horizon Bank operates in 12 states concentrated in the southern U.S. The Company and its subsidiaries offer commercial, private banking, consumer, small business, wealth and trust management, retail brokerage, capital markets, fixed income, and mortgage banking services. First Horizon has been recognized as one of the nation's best employers by Fortune and Forbes magazines and a Top 10 Most Reputable U.S. Bank. More information is available at www.FirstHorizon.com.

About Bristol Motor Speedway
Bristol Motor Speedway, known as The Last Great Colosseum, sits in the mountains of Northeast Tennessee near the Virginia state line. The 0.533-mile concrete oval, with 28-degree banking, hosts two major NASCAR Cup Series weekends each year, the tradition-rich Food City 500 weekend in April and the crown jewel Bass Pro Shops Night Race Chase weekend in September. The venue has staged iconic moments such as the 2016 Pilot Flying J Battle at Bristol football game between the University of Tennessee and Virginia Tech (NCAA-record 156,990 fans), the 2025 MLB Speedway Classic between the Atlanta Braves and Cincinnati Reds (MLB regular-season record crowd of 91,032), the 2020 NASCAR All-Star Race, the rebirth of NASCAR Cup Series racing on dirt from 2021–2023 and sold-out concerts for Morgan Wallen and Kenny Chesney. Fans enjoy Colossus TV, the world's largest outdoor center-hung four-sided screen video board. The adjacent Bristol Dragway is the home to the NHRA Super Grip Thunder Valley Nationals, and the dragway can transform into the Thunder Valley Amphitheatre for music concerts. Opened in 1961 and acquired by Speedway Motorsports in 1996, BMS remains one of America's most unique and versatile sports and entertainment destinations. For more information, please visit www.bristolmotorspeedway.com.

SOURCE First Horizon Bank

Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Selkirk Copper Mines Inc. (TSXV: SCMI) (FSE: IO20) (OTCQB: SKRKF) is advancing plans to restart a former producing copper-gold-silver mine in the Yukon, targeting a return to production by 2028. The company is refining the resource, updating engineering and mine plans, and refreshing permits to support a potential 12 to 15-year mine life.

Selkirk Copper Mines Inc. (TSXV: SCMI) (FSE: IO20) (OTCQB: SKRKF)
https://selkirkcopper.com/

Cannot view this video? Visit:
www.b-tv.com/post/ceo-clips-selkirk-copper-mines-targets-2028-restart-of-former-yukon-producer-btv-60

About BTV - Business Television:

For over 25 years, BTV has been a capital markets focused TV production and Digital Marketing Agency. BTV helps companies increase their brand awareness to a national retail and institutional investor audience, combining unique content creation and major distribution services on top tier networks including Bloomberg, CNBC, FOX Business News and financial sites. The BTV suite of strategic products include: BTV- Business Television Show, CEO Clips™, TV Branding Ads, Digital, Lead Gen, Social and Direct Email Marketing Campaigns that reach investors where they research and live on-air and online.

Discover Investment Opportunities!

www.b-tv.com/theagency

About CEO Clips:
CEO Clips - are short company video profiles broadcast to a large audience of investors on TV and 15+ financial sites including Reuters, Yahoo!Finance, and Wall Street Journal.

Contact: Trina Schlingmann (604) 664-7401 x 5 [email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/289139

Source: CEO Clips

World's preeminent energy conference to focus on 'Convergence and Competition: Energy, Technology and Geopolitics.' Learn more at www.ceraweek.com

, /PRNewswire/ -- Nobel Laureate Maria Corina Machado will address delegates at the 44th annual CERAWeek by S&P Global, March 23-27 in Houston. She will join the world's energy industry leaders, experts, government officials and policymakers, as well as leaders from the technology, financial and industrial communities addressing this year's conference.

In shaping a vision for Venezuela's future, Ms. Machado has been a consistent advocate for restoring the institutional foundations necessary to attract large-scale private investment. Her remarks will outline a pathway toward a competitive, rules-based energy sector, anchored in legal certainty, transparent governance and full market opening.

She will present a forward-looking vision for Venezuela as a reliable, investment-grade energy partner for the Western Hemisphere, highlighting the country's potential not only as one of the world's largest hydrocarbon producers, but as a platform for integrated energy development, technological innovation and long-term capital deployment.

"It is an honor to welcome Ms. Machado to CERAWeek," said Daniel Yergin, conference chair and Vice Chairman of S&P Global. "At a pivotal moment of transition for Venezuela, the Western Hemisphere and the world, her insights on markets, the energy industry and Venezuela's future will be a highly anticipated addition to the important dialogues taking place at the conference and will do much to frame the conversation on the future and timing of investment in her country."

CERAWeek 2026 Convergence and Competition: Energy, Technology and Geopolitics will explore ideas and strategies for a world where energy markets are increasingly entwined with new and existing technologies—even as geopolitical rivalries and economic competition fray alliances and fracture supply chains. The conference program will spotlight the breakthroughs, cross-industry connections and powerful partnerships that can accelerate the transformation of the global energy system.

CERAWeek 2026 Key Themes

The CERAWeek 2026 conference program will explore key themes related to:

Politics, Economics, Trade and Supply Chains Policy, Regulations and Stakeholders Oil Value Chain Natural Gas and LNG Power, Renewables, Generation and Grid AI and Digital Minerals and Mining Electrification Technologies Investment and Financing Chemicals and Materials Business Strategies The Innovation Ecosystem Managing Emissions Low-Carbon Fuels and Mobility Climate and Sustainability Workforce Strategy The week-long event will also include the CERAWeek Innovation Agora, serving as the center of technology and innovation programming at the conference. Featuring a community of technologists, startup entrepreneurs, venture capitalists and investors, thought leaders, policymakers and corporate innovators, the Innovation Agora will showcase transformational technology platforms in energy and adjacent industries ranging across AI, decarbonization, low carbon fuels, cybersecurity, hydrogen, nuclear, mining and minerals, mobility, automation and more.

The conference program will wrap Friday, March 27 with a new feature—Look Forward—that will focus on economics, politics and technology.

Speakers

CERAWeek 2026 speakers will include (partial list):

Shaikh Nawaf Al-Sabah – Deputy Chairman and CEO, Kuwait Petroleum Corporation Linda Z. Cook – CEO, Harbour Energy Hon. Paul M. Dabbar – Deputy Secretary, U.S. Department of Commerce Claudio Descalzi – CEO, Eni Greg Ebel – President, CEO and Director, Enbridge Inc. James D. Farley, Jr. – President and CEO, Ford Motor Company Jim Fitterling – Chair and CEO, Dow Jack Fusco – President and CEO, Cheniere Energy Daniel González – Vice-Minister of Energy and Mining, Ministry of Economy, Argentina Russell Hardy – CEO, Vitol Vicki Hollub – CEO, Occidental Petroleum Ditte Juul Jørgensen – Director-General for Energy, European Commission John Ketchum – Chairman, President and CEO, NextEra Energy Markus Krebber – CEO, RWE AG Ryan Lance – Chairman and CEO, ConocoPhillips Chris Levesque – President and CEO, TerraPower Olivier Le Peuch – CEO, SLB Tadashi Maeda – Chairman of the Board, Japan Bank for International Cooperation (JBIC) David H. McCormick – United States Senator, Pennsylvania Tomohide Miyata – Representative Director and CEO, ENEOS Holdings, Inc. Amin H. Nasser – President and CEO, Saudi Aramco Anders Opedal – President and CEO, Equinor Marcel van Poecke, Chairman of Energy, The Carlyle Group Ruth Porat – President and Chief Investment Officer, Alphabet and Google Patrick Pouyanné – Chairman of the Board and CEO, TotalEnergies Gen. Randall Reed – Commander, U.S. Transportation Command (USTRANSCOM) Toby Rice – President and CEO, EQT Corporation Paolo Rocca – President and CEO, Techint Group Wael Sawan – CEO, Shell Lorenzo Simonelli – Chairman and CEO, Baker Hughes Hon. Danielle Smith – Premier of Alberta, Government of Alberta Michael Smith – Chairman, CEO and Founder, Freeport LNG Laura V. Swett – Chairman, Federal Energy Regulatory Commission (FERC) Mike Wirth – Chairman of the Board and CEO, Chevron Chris Wright – Secretary of Energy, U.S. Department of Energy Zoë Yujnovich – CEO, National Grid Lee Zeldin – Administrator, U.S. Environmental Protection Agency (EPA) Visit www.ceraweek.com for a complete list of speakers and the most up-to-date program information (subject to change).

Registration Information

CERAWeek by S&P Global 2026 will be held March 23-27 at the Hilton Americas—Houston. Further information and delegate registration is available at www.ceraweek.com.

Media Accreditation

Media registration is now open. Members of the media interested in covering CERAWeek 2026 are required to apply for accreditation.

Applications are subject to approval and can be submitted at the following link: https://reg.spglobal.com/flow/spglobal/cw26/media-reg/login

Media Contacts:

Jeff Marn
S&P Global Energy
+1 202 463 8213
[email protected]

About S&P Global

S&P Global (NYSE: SPGI) enables businesses, governments, and individuals with trusted data, expertise, and technology to make decisions with conviction. We are Advancing Essential Intelligence through world-leading benchmarks, data, and insights that customers need in order to plan confidently, act decisively, and thrive economically in a rapidly changing global landscape.

From helping our customers assess new investments across the capital and commodities markets to guiding them through the energy expansion, acceleration of artificial intelligence, and evolution of public and private markets, we enable the world's leading organizations to unlock opportunities, solve challenges, and plan for tomorrow – today. Learn more at www.spglobal.com.

SOURCE S&P Global

LOS ANGELES, March 19, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paysafe Limited (“Paysafe” or “the Company”) (NYSE: PSFE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between March 4, 2025 and November 12, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before April 7, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Paysafe had material exposure to a high-risk client in its e-commerce business. The Company understated its credit loss reserves and/or write-offs. The Company suffered from higher risk Merchant Category Codes, which it failed to disclose. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Paysafe, investors suffered damages.

Join the case to recover your losses

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.        

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

The Schall Law Firm

Commercial Metals (CMC - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended February 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on March 26. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis manufacturer and recycler of steel and metal products is expected to post quarterly earnings of $1.28 per share in its upcoming report, which represents a year-over-year change of +392.3%.

Revenues are expected to be $1.98 billion, up 13% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Commercial Metals?For Commercial Metals, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -14.62%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Commercial Metals will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Commercial Metals would post earnings of $1.55 per share when it actually produced earnings of $1.84, delivering a surprise of +18.71%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Commercial Metals doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Key Takeaways Fed signals fewer cuts; oil shock keeps inflation risks elevated and policy cautious.Weak job growth raises risks of deeper cuts later despite current Fed pause.Strong dollar, rising yields favor income ETFs and inverse gold strategies as of now. The Federal Reserve kept interest rates unchanged at 3.5%–3.75% following its two-day policy meeting on Wednesday, in line with market expectations. Alongside the decision, policymakers released their first Summary of Economic Projections (SEP) for 2026, maintaining a median forecast of one rate cut for 2026, unchanged from their December outlook.

Markets reacted negatively after Fed Chair Jerome Powell highlighted growing uncertainty tied to the recent oil shock, noting that progress on inflation has been slower than anticipated.

Labor Market Shows Signs of WeaknessPowell acknowledged that job creation has slowed significantly. Recent data showed the unemployment rate ticking up to 4.4% in February, alongside a loss of 92,000 jobs. Downward revisions to prior months further highlight a stagnating employment trend, raising concerns about economic resilience.

Delayed Cuts May Lead to Bigger Moves LaterRising oil prices could keep inflation elevated in the short term, prompting the Fed to remain cautious. However, prolonged uncertainty may weigh on hiring and economic activity, potentially forcing the Fed to implement more rate cuts later. For now, policymakers appear inclined to wait and assess incoming data before making their next move.

No Stagflation for Now Fed Chair Powell dismissed concerns that the U.S. economy is entering stagflation—a challenging mix of high inflation, weak growth, and elevated unemployment. While acknowledging some tension between the Fed’s goals of price stability and a healthy labor market, Powell emphasized that current conditions do not fit the definition of stagflation.

He noted that the term is rooted in the 1970s, when unemployment was in double digits, inflation was extremely high, and overall economic stress was severe, as quoted on Yahoo Finance.

Time for Inverse Gold?Gold has dropped for a seventh straight day as the escalating war in the Middle East has driven oil prices higher and reduced prospects for a near-term U.S. interest-rate cut. Gold typically performs better in a low-rate environment. Gold performs better in a low-rate environment. ProShares UltraShort Gold (GLL) has gained about 13.7% over the past week and has added about 5.7% over the past month (as of Mar. 18, 2026).

Time for U.S. Dollar ETFs?As the Fed is likely to cut rates less frequently this year, the U.S. dollar may gain strength. Invesco DB US Dollar Index Bullish Fund (UUP) has added 0.9% over the past week and gained 2.7% over the past month.

Time for benchmark-Beating Cash-Like ETFs? Benchmark U.S. Treasury yields have risen from 4.05% to 4.26% so far this month, with a high of 4.28% reached on March 13, 2026. Note that legendary investor Warren Buffett has typically focused on companies with strong cash reserves and cautioned against making investments merely to reduce cash holdings.

Investors can consider the cash-like ETF JPMorgan Ultra-Short Income ETF (JPST - Free Report) in uncertain times or when value is hard to find elsewhere. The ETF is down 0.1% this year (as of Mar. 18, 2026) and yields 4.36% annually. It charges 18 bps in fees.

High-Dividend ETFs: a Good BetSince there is an uptick in bond yields, ETFs that offer higher current income may remain in demand. Global X SuperDividend ETF (SDIV - Free Report) (yields 9.62% annually and charges 58 bps in fees) could be considered in this kind of scenario to earn solid current income. The ETF is up 2.6% this year, beating State Street SPDR S&P 500 ETF Trust (SPY - Free Report) which is down 3.2% in the year to date frame.

Key Takeaways RIO delivered 326.2M tons of shipments and 327.3M tons of production despite early 2025 disruptions.Pilbara recovery, Gudai-Darri ramp-up and blend strategy boosted efficiency and output.RIO advances Rhodes Ridge and Simandou projects while facing weather, cost and price risks. Rio Tinto Group (RIO - Free Report) delivered resilient iron ore performance in 2025, supported by strong execution across its Pilbara operations. During the year, Pilbara iron ore shipments reached 326.2 million tons, while production stood at 327.3 million tons, remaining stable despite weather-related disruptions earlier in 2025.

The Pilbara facility remains the backbone of Rio Tinto’s iron ore business. Operational recovery following cyclone impacts in the first quarter of 2025, coupled with improved rail and port efficiency, drove stronger performance in the second half of the year. The Gudai-Darri mine continued to ramp up, contributing to record mining rates from April onward. Also, the rollout of the revised Pilbara Blend strategy enhanced product mix by reducing lower-grade SP10 volumes, supporting overall realization and efficiency.

Also, several major growth projects of the company are progressing. In December 2025, RIO’s Rhodes Ridge joint venture approved a $191 million feasibility study to develop one of the world’s major undeveloped iron ore deposits in Western Australia, aiming for an initial annual production of 40-50 million tons. The study is expected to conclude in 2029. In October 2025, at the Simandou iron ore project in Guinea, the first ore was loaded and transported, marking the start of commissioning across the mine, rail and port infrastructure.

However, some constraints remain. Pilbara facility’s performance continues to be subject to weather risks, approval timelines for mining areas, and cost pressures from inflation and currency movements. Iron ore price volatility could impact earnings as well, despite stable volumes.

Overall, while external risks persist, the strength and resilience of the Pilbara facility are likely to remain key drivers of the company’s near-term performance.

Snapshot of RIO’s PeersAmong its major peers, Trilogy Metals Inc. (TMQ - Free Report) continues to make steady progress at the Ambler mining district. Although Trilogy is not yet in production, it is taking a step ahead with Ambler Metals LLC, which is a joint venture with South32 Limited. In July 2025, Trilogy began a multi-year core re-boxing program to protect drill core for long-term future use.

USAR’s other peer, NioCorp Developments Ltd. (NB - Free Report) , is working to move its Elk Creek Project in Nebraska closer to production. In August 2025, NioCorp completed its first drilling program at the Elk Creek Project on schedule and within budget. In February 2026, NioCorp started construction of the main underground access for its Elk Creek Critical Minerals Project in southeast Nebraska.

RIO's Price Performance, Valuation & EstimatesShares of Rio Tinto have gained 37.8% in the past six months compared with the industry’s growth of 24.9%.

Image Source: Zacks Investment Research

From a valuation standpoint, RIO is trading at a forward price-to-earnings ratio of 10.20X, below the industry’s average of 13.69X. Rio Tinto carries a Value Score of A.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for RIO’s 2026 earnings has been on the rise over the past 60 days.

Image Source: Zacks Investment Research

Rio Tinto currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The increasing demand for business process outsourcing (BPO), driven by its flexibility and reduced costs, aids the Zacks Outsourcing industry. The upsurge in data encryption and cybersecurity risks necessitates the need to pivot toward outsourcing. Trends like the Internet of Things (IoT), cloud computing, Artificial Intelligence (AI) and Machine Learning (ML) are transforming the sector.

Investors can consider Capgemini SE (CGEMY - Free Report) and Adecco Group AG (AHEXY - Free Report) from the Outsourcing market.

About the Industry Outsourcing involves delegating a company's internal operations to external resources or third-party contractors to enhance operational efficiency. Within the Zacks Outsourcing sector, one can find companies that provide human capital, business management and IT solutions, primarily catering to small and medium-sized enterprises. These services encompass a broad spectrum, including HR support, payroll management, administration of benefits, retirement planning and insurance services. Certain firms excel in delivering business process services, with a strong focus on transaction processing, analytics and global automation solutions. This outsourcing approach empowers businesses to concentrate on their core competencies while external experts manage these critical functions.

What's Shaping the Future of the Outsourcing Industry? Consistent Growth in Business Process & IT Outsourcing: BPO services witness higher demand due to greater flexibility, lower costs and improved service quality. Per our long-term outlook, outsourced IT services will cover a wide array of functions, including programming and technical support, which will boost their demand. This will enable companies to outsource their entire IT departments, lowering costs and allowing them to focus on core operations. The shortage of in-house engineering talent will drive the outsourcing trend.

Urgency of Cybersecurity Measures: The demand for robust data encryption and cybersecurity measures is increasing on the back of heightened public awareness and changing cyber threats, such as ransomware and national-level cyberattacks. To mitigate cybersecurity threats, companies are focusing on employee security awareness training and breach detection systems. Businesses are increasingly turning to outsourced cybersecurity services to lower risks, maintain compliance and support scalability in their operations.

Changing Industry Trends: The outsourcing sector is being transformed by trends such as IoT, cloud computing, AI and ML. These innovations improve efficiency, support innovation and increase competitiveness, transforming the outsourcing landscape for businesses to streamline operations. For instance, IoT data can be collected, processed and analyzed in the cloud, enabling real-time decision-making and predictive maintenance for clients. By integrating AI and ML into customer support outsourcing, companies can provide swifter, effective and consistent customer support while optimizing operational costs.

Zacks Industry Rank Indicates Dull Near-Term Prospects The Zacks Outsourcing industry, which is housed within the broader Zacks Business Services sector, currently carries a Zacks Industry Rank #227. This rank places it in the bottom 7% of 244 Zacks industries.

The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates continued underperformance in the near term. Our research shows that the top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.

Before we present a few stocks that you may want to consider for your portfolio, let us take a look at the industry’s recent stock market performance and current valuation.

Industry Underperforms Sector & S&P 500 Over the past year, the Zacks Outsourcing industry underperformed the broader Zacks Business Services sector and the Zacks S&P 500 composite.

The industry has declined 47.6% over this period compared with the broader sector’s 18.2% dip and against the Zacks S&P 500 composite’s 23.2% rally.

1-Year Price Performance

Industry Trades Cheaper Than Sector & S&P 500 On the basis of forward 12-month price-to-earnings (P/E), commonly used for valuing outsourcing stocks, the industry is currently trading at 18.17X compared with the S&P 500’s 21.63X and the sector’s 17.79X.

In the past five years, the industry has traded as high as 33.22X and as low as 4.94X, with the median being 17.03X, as the charts below show.

Price-to-Forward 12 Months’ P/E Ratio

2 Outsourcing Stocks Poised for Growth Capgemini: This company provides expert consulting, technology and engineering services, as well as specialized strategies, globally. Capgemini finished 2025 with a strong note, delivering 3.4% year-over-year top-line growth at constant currency. The company witnessed growth across all regions over the past four quarters.

The company reported a solid book-to-bill ratio of 1.08 for 2025 and 1.21 for the fourth quarter of 2025. It serves as concrete evidence for consistent commercial traction, fueled by a higher number of large deals. Despite cost pressure due to higher bench in Continental Europe, CGEMY skillfully managed to end the year with an operating margin of 13.3% and a stable organic free cash flow.

The Defense sector continued to deliver positively with double-digit growth in 2025. Furthermore, CGEMY’s Intelligent Operations, which leverages AI to reshape and run entire client business operations, displayed a growth pipeline of opportunities.

Capgemini has also made significant progress in its ESG goals. On the environment front, it has propelled toward the target of being net-zero across all scopes by 2040, reaching 100% renewable electricity for all operations. It has made notable progress in gender balance with a 13-point hike in women executives since 2019, highlighting an inclination toward a modernized governance structure.

The Zacks Consensus Estimate for the company’s 2026 EPS of $3.18 has risen 11.6% over the past 60 days.

CGEMY carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

Adecco: This company offers human resource services to businesses and organizations across the globe. During the fourth-quarter 2025 earnings call, the company disclosed it managed to gain 245 basis points (bps) in its market share relative to key competitors with sustained positive momentum.

The top line gained 3.9% year over year during the fourth quarter of 2025 and achieved a stable gross margin of 19.2%, banking on a diversification strategy. The company successfully improved productivity by 11% and delivered a strong drop-down ratio of more than 80%. It resulted in an EBITA margin expansion of 60 bps year over year. A 70-bps dip in SG&A expenses as a percentage of revenues added to the margin expansion as well.

The company maintained a high conversion rate of earnings into cash, as evidenced by a 102% cash conversion ratio. AHEXY excelled at managing debt as it experienced a clear dip in leverage ratio to 2.4X, down 0.2X year over year and 0.6X sequentially. In terms of product, AI-powered Career Studio showed significant improvement in helping people find jobs in 32 days than those who do not use this product.

The Zacks Consensus Estimate for the company’s 2026 EPS has been unchanged at $1.55 over the past 60 days.

AHEXY currently has a Zacks Rank of #3 (Hold).

Key Takeaways Barrick advances major gold and copper projects like Goldrush, Lumwana and Reko Diq.Agnico Eagle boosts growth with Odyssey, Detour Lake, Hope Bay and Upper Beaver.B stock is up 109.9% in the past year, while AEM has gained 86.1% amid the gold price rally. Barrick Mining Corporation (B - Free Report) and Agnico Eagle Mines Limited (AEM - Free Report) are two leading players in the gold mining space with global operations and diversified portfolios. While gold prices have fallen from their January 2026 highs, they remain favorable. Against this backdrop, comparing the two industry giants is particularly relevant for investors seeking exposure to the precious metals sector.

After surging roughly 65% in 2025, gold entered 2026 with strong momentum. Heightened geopolitical strains, a weaker U.S. dollar and concerns over the independence of the Federal Reserve pushed bullion to record highs, with prices climbing to nearly $5,600 per ounce in late January. The rally was followed by a brief pullback to below $4,900 per ounce due to aggressive profit-taking and a rebound in the U.S. dollar. However, bargain hunting after the sharp selloff lifted prices back above $5,000 per ounce.

Bullion strengthened earlier this month again, surging past $5,400 per ounce on March 2, as safe-haven demand spiked, following joint U.S.-Israel strikes on Iran. Gold prices have since retreated from those levels amid a stronger U.S. dollar and inflation concerns tied to surging oil prices. The Federal Reserve kept interest rates unchanged amid a spike in oil prices due to the ongoing war and projected only one rate cut this year. Fed’s hawkish tone further weighed on gold prices, dragging it below $4,900 per ounce.

Sustained central-bank purchases, safe-haven demand tied to prevailing geopolitical tensions due to the Middle East war and broader macroeconomic uncertainties are likely to support gold prices moving ahead.

Let’s dive deep and closely compare the fundamentals of these two Canada-based gold miners to determine which one is a better investment now.

The Case for BarrickBarrick is well-placed to benefit from the progress in key growth projects, which should significantly contribute to its production. Its major gold and copper growth projects, including Goldrush, the Pueblo Viejo plant expansion and mine life extension, Fourmile, Lumwana Super Pit and Reko Diq, are underway. These projects are advancing on schedule and within budget, laying the groundwork for the next generation of profitable production.

The Goldrush mine is ramping up to the targeted 400,000 ounces of production per annum by 2028. Bordering Goldrush is the 100% Barrick-owned Fourmile, which is yielding grades double those of Goldrush and is anticipated to become another Tier One mine. The project has progressed to a prefeasibility study on the back of a successful drilling program, which shows significant resource growth potential. The Reko Diq copper-gold project in Pakistan is designed to produce 460,000 tons of copper and 520,000 ounces of gold annually in its second development phase. The first production is expected by the end of 2028.

Moreover, the $2-billion Super Pit Expansion Project at its Lumwana mine is progressing steadily, accelerating its shift into a Tier One copper mine. Barrick stated that the Lumwana expansion is the result of a significant turnaround, transforming the mine from an underperforming asset into a vital part of both its global copper portfolio and Zambia’s long-term development strategy. The expansion is expected to produce 240,000 tons of copper annually.

Barrick has a solid liquidity position and generates healthy cash flows, positioning it well to take advantage of attractive development, exploration and acquisition opportunities, drive shareholder value and reduce debt. At the end of fourth-quarter 2025, Barrick’s cash and cash equivalents were around $6.7 billion. It generated strong operating cash flows of roughly $2.7 billion in the fourth quarter, up 13% year over year, while free cash flow rose 9% year over year to around $1.6 billion. For full-year 2025, operating cash flow surged 71% to around $7.7 billion, and free cash flow shot up 194% to $3.9 billion.

Barrick returned $2.4 billion to its shareholders in 2025 through dividends and repurchases. It repurchased shares worth $1.5 billion during 2025, including $500 million in the fourth quarter. The company increased its dividend to 42 cents per share for the fourth quarter of 2025, marking a 140% increase over the third quarter. It also announced a new dividend policy that targets a total payout of 50% of attributable free cash flow on an annualized basis.

   Barrick offers a dividend yield of 3.9% at the current stock price. Its payout ratio is 29% (a ratio below 60% is a good indicator that the dividend will be sustainable), with a five-year annualized dividend growth rate of roughly 5.9%.

Barrick, however, is challenged by higher costs, which may weigh on its margins. Its total cash costs per ounce of gold and all-in-sustaining costs (AISC) — a critical cost metric for miners — increased around 15% and 9% year over year, respectively, in the fourth quarter, and rose from the previous quarter as well. AISC of $1,581 increased from the year-ago quarter due to higher total cash costs per ounce. AISC also rose 10% year over year to $1,637 in 2025. Lower year-over-year production, partly due to the suspension of operations at the Loulo-Gounkoto mine, contributed to the rise in its unit costs.

For 2026, Barrick projects AISC in the range of $1,760-$1,950 per ounce, indicating a significant year-over-year increase at the midpoint. Cash costs per ounce are forecast to be $1,330-$1,470, up from $1,199 in 2025. Lower grades mined, higher prices of key consumables and raised gold price assumptions are expected to contribute to increased costs in 2026. The increase also reflects a higher cost base at Loulo-Gounkoto as the company ramps up mining following the return of control in December 2025.

The Case for Agnico EagleAgnico Eagle is focused on executing projects that are expected to provide additional growth in production and cash flows. It is advancing its key value drivers and pipeline projects, including the Odyssey project in the Canadian Malartic Complex, Detour Lake, Hope Bay, Upper Beaver and San Nicolas.

The Hope Bay Project, with proven and probable mineral reserves of 3.4 million ounces, is expected to play a significant role in generating cash flow in the years to come. The processing plant expansion at Meliadine was completed and commissioned in the second half of 2024, with mill capacity expected to increase to roughly 6,250 tons per day. At Canadian Malartic, Agnico Eagle is advancing the transition to underground mining with the construction of the Odyssey mine and executing other opportunities to beef up annual production. Production from East Gouldie is expected to commence from the ramp in the first quarter of 2026.

At Hope Bay, drilling results at Patch 7 also suggest the potential for mineral resource expansion. Moreover, drilling at the Marban deposit, added through the acquisition of O3 Mining, focuses on mineral reserve and mineral resource expansion. AEM also continued to work on a feasibility study at San Nicolas. At Detour Lake, AEM advanced the development of the exploration ramp during the fourth quarter.

The merger with Kirkland Lake Gold established Agnico Eagle as the industry's highest-quality senior gold producer. The integrated entity now has an extensive pipeline of development and exploration projects to drive sustainable growth. It also has the financial flexibility to fund a strong pipeline of growth projects.

AEM has a robust liquidity position and generates substantial cash flows, which enable it to maintain a strong exploration budget, finance a strong pipeline of growth projects, pay down debt and drive shareholder value. Its operating cash flow was roughly $2.1 billion in the fourth quarter, up around 87% from the year-ago quarter. Operating cash flow for full-year 2025 was a record $6.8 billion, driven by operational efficiencies.

AEM recorded fourth-quarter free cash flow of roughly $1.3 billion, more than doubling the prior-year figure of $570 million. For the full year, free cash flow was a record $4.4 billion, up 105% year over year. The upside was backed by the strength in gold prices and robust operational results. The company remains focused on paying down debt using excess cash, with total long-term debt reducing by roughly $950 million in 2025, ending the year with $196 million.

The company ended 2025 with a significant net cash position of nearly $2.7 billion, driven by the increase in cash position and reduction in debt. AEM also returned around $1.4 billion to its shareholders in 2025 through dividends and share buybacks. It raised its quarterly dividend by 12.5% to 45 cents per share.

Agnico Eagle's long-term debt-to-capitalization is just around 1.16%, lower than Barrick’s 11.46%. AEM offers a dividend yield of 0.9% at the current stock price. It has a five-year annualized dividend growth rate of 2.6%. AEM has a payout ratio of 19%.

B & AEM: Price Performance, Valuation & Other ComparisonsBarrick stock has surged 109.9% in the past year, while AEM stock has rallied 86.1% compared with the Zacks Mining – Gold industry’s increase of 103.9%.

Image Source: Zacks Investment Research

Barrick is currently trading at a forward 12-month earnings multiple of 10.76, lower than its five-year median. This represents a roughly 10.3% discount when stacked up with the industry average of 12X.

Image Source: Zacks Investment Research

Agnico Eagle is trading at a premium to Barrick. The AEM stock is currently trading at a forward 12-month earnings multiple of 14.72, above the industry. 

Image Source: Zacks Investment Research

AEM’s return on equity of 18.09% is higher than B’s 12.1%. This reflects Agnico Eagle’s efficient use of shareholder funds in generating profits.

Image Source: Zacks Investment Research

How Does Zacks Consensus Estimate Compare for B & AEM?The Zacks Consensus Estimate for B’s 2026 sales and EPS implies a year-over-year rise of 12.9% and 49.2%, respectively. The EPS estimates for 2026 have been trending higher over the past 60 days.

Image Source: Zacks Investment Research

The consensus estimate for AEM’s 2026 sales and EPS implies year-over-year growth of 38% and 60.4%, respectively. The EPS estimates for 2026 have been trending northward over the past 60 days.

Image Source: Zacks Investment Research

B or AEM: Which is the Better Pick Now?Both Barrick and Agnico Eagle have a strong pipeline of development projects, solid financial health and strong earnings growth prospects, and are seeing favorable estimate revisions. Favorable gold prices are also expected to drive their margins and cash flows. AEM's higher growth projections and superior return on equity suggest that it may offer better investment prospects in the current market environment. AEM’s lower leverage also indicates lesser financial risks. Investors seeking exposure to the gold space might consider Agnico Eagle as the more favorable option at this time.

B currently carries a Zacks Rank #3 (Hold), while AEM sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

AECOM's ACM aggressive push into Artificial Intelligence (AI) is not just a buzzword, but may be a meaningful margin catalyst. In its recent first-quarter fiscal 2026 earnings release, the company reported an adjusted operating profit of $264 million, which was up 10% from the year-ago quarter, with adjusted operating margin improving 100 bps to 16.4%.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

© Spencer Platt / Getty Images

YieldMax PYPL Option Income Strategy ETF (NYSEARCA:PYPY) launched September 2023 with a simple pitch: collect weekly income from one of the world’s most recognized payment platforms. The fund sells covered call options on PayPal Holdings (NASDAQ:PYPL), pocketing the option premium and distributing it to shareholders weekly. For income-focused investors, that sounds appealing. The problem is that the strategy is only as durable as the stock underneath it, and PayPal has had a rough year.

The PayPal logo is prominently featured on the modern office building that serves as its headquarters. A Stock That Has Been Sliding for Months PayPal shares are down roughly 36% since late October 2025, falling from around $73 to $46 as of March 17, 2026. Year-to-date, the stock is down nearly 21%. The catalyst was a Q4 2025 earnings report that missed on both revenue and earnings, followed by 2026 guidance pointing to further EPS declines.

Non-GAAP EPS came in at $1.23 against a $1.29 estimate, while revenue of $8.676 billion fell short of the $8.778 billion consensus. Interim CEO Jamie Miller acknowledged the shortfall directly on the earnings call: “Our execution has not been what it needs to be. We have not moved fast enough or with the level of focus required.” The branded checkout business, which management had positioned as a core growth driver, underperformed in Q4, down from the prior quarter.

For 2026, PayPal guided for non-GAAP EPS ranging from a low-single-digit decline to slightly positive versus 2025’s $5.31. The company also withdrew its multi-year outlook entirely. Securities class action lawsuits followed the earnings release, adding legal uncertainty to an already complicated picture.

The Primary Risk: NAV Erosion That Distributions Cannot Offset When the underlying stock in a covered call ETF falls sharply, two things happen simultaneously and both hurt the investor. The fund’s net asset value drops in lockstep with the stock, and the option premiums it collects shrink because lower-priced stocks generate less absolute premium income even when implied volatility stays elevated.

PYPY’s distribution history shows this compression clearly. In September 2024, the fund paid $1.62 per share in a single distribution. By early 2026, weekly payments had fallen to a range of $0.17 to $0.49 per share. The fund’s stated dividend yield sits at roughly 4.4%, but that figure reflects a NAV base already eroded by the stock’s decline. Investors who bought at higher prices are earning that yield on a smaller and smaller principal.

Return of capital distributions compound this problem. When the fund cannot generate enough premium to cover its distribution target, it returns investors’ own principal as part of the payout. The check arrives, the NAV shrinks further, and next week’s premium income is calculated against an even smaller base.

The Secondary Risk: Volatility That Doesn’t Help Covered call strategies benefit from high implied volatility because it makes options more expensive to sell. The VIX currently sits at 23.51, elevated relative to its December 2025 trough of 13.47. In theory, that should support premium income. But PYPL-specific volatility is being driven by genuine uncertainty around the CEO transition, securities litigation, and execution risk, not a temporary spike that will resolve cleanly. Volatility driven by fundamental deterioration tends to keep the stock range-bound or declining, which means the fund collects some premium but loses more in NAV.

What to Watch Three signals are worth monitoring for anyone researching PYPY.

PayPal’s branded checkout trajectory. Management guided for slightly positive to low-single-digit branded checkout growth in 2026. If Q1 results, expected around late April 2026, show further deceleration, the stock is likely to face renewed pressure. PayPal’s investor relations page publishes earnings releases directly. Weekly distribution amounts. YieldMax publishes distribution data weekly. A sustained drop in per-share distributions signals that premium income is compressing. Analysts note that per-share distributions should be evaluated relative to current NAV rather than purchase price to assess true yield. The VIX. Track it through FRED’s VIXCLS series. A sustained drop below 15 means option premiums across the market are thin, which directly reduces what PYPY can generate and distribute. The fund’s net assets stand at roughly $24 million, a small pool that limits its ability to absorb prolonged NAV erosion. With PayPal guiding for declining earnings in 2026 and a new CEO still finding his footing, the stock’s path back to higher levels where PYPY generated its best distributions is far from clear. The weekly check reflects the current state of a declining underlying stock, not a stable income stream.

Key Takeaways Brown-Forman drives growth through premiumization, focusing on high-quality brands and global expansion.BF.B expands premium-plus portfolio and RTD offerings, boosting engagement and incremental growth.Cost discipline, restructuring and emerging market focus support efficiency and long-term strategy. Brown-Forman Corporation (BF.B - Free Report) leverages its brand strength and premiumization strategy as important drivers for long-term growth. By focusing on well-established, globally recognized labels and expanding premium expressions, the company is reinforcing pricing power, supporting margins and prioritizing value-led growth.

The company is focused on leveraging its iconic brands, expanding its premium portfolio, driving innovation and bolstering global growth. Brown-Forman’s premiumization strategy centers on elevating its portfolio by prioritizing high-quality, premium brands to drive growth and align with consumers’ increasing preference for authentic spirits. The company is actively focusing on expanding its premium-plus and super-premium portfolio, particularly in emerging markets where consumer demand remains more resilient.

Brown-Forman is strengthening its premium positioning through route-to-consumer initiatives as well. A key priority is portfolio premiumization and innovation, with continued investment in premium-plus brands and new product launches like flavored whiskey variants, which are generating strong consumer engagement and helping drive incremental growth. The company is also advancing its Ready-to-Drink portfolio, expanding offerings such as New Mix and testing launches in new markets.

In addition, operational efficiency remains a priority, with the company benefiting from workforce restructuring and cost discipline, which are helping streamline operations, improve agility and reduce expenses. Brown-Forman is also leveraging its global footprint and geographic expansion strategy, particularly in emerging markets and Travel Retail, where it is allocating more resources to high-growth regions. The company has been seeing momentum across its Emerging markets for a while now.

However, a challenging macroeconomic landscape, including soft demand, weak consumer confidence and reduced discretionary spending, has been concerning. Brown-Forman’s results revealed broad-based softness across a few categories, highlighting uneven demand momentum. Nevertheless, the company’s strategy is centered on innovation, premiumization, RTD expansion, route-to-market optimization and cost efficiency, positioning it to navigate near-term headwinds alongside driving sustainable growth.

BF.B’s Price Performance, Valuation and EstimatesBrown-Forman shares have lost 18.4% in the past six months compared with the industry’s 6.5% growth.

Image Source: Zacks Investment Research

From a valuation standpoint, BF.B trades at a forward price-to-earnings ratio of 13.58X, compared with the industry’s average of 14.73X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for BF.B’s fiscal 2026 and fiscal 2027 earnings per share (EPS) indicates a year-over-year decline of 6% and 2.6%. The company’s EPS estimate for fiscal 2026 has increased while that of fiscal 2027 has decreased in the past 30 days.

Image Source: Zacks Investment Research

Brown-Forman currently carries a Zacks Rank #3 (Hold).

Stocks to Consider in the Consumer Staples SpaceFreshpet, Inc. (FRPT - Free Report) , which is a pet food company, currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 8.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 50%, on average.

Nomad Foods Limited (NOMD - Free Report) , which manufactures and distributes frozen foods, currently carries a Zacks Rank of 2.

The Zacks Consensus Estimate for Nomad Foods’ current financial-year earnings is expected to rise 6.2% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 2.9%, on average.

Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters.

The Zacks Consensus Estimate for Medifast’s current financial-year earnings indicates growth of 30.5% from the year-ago number.

Dante Disparte, Circle’s (NYSE:CRCL) Chief Strategy Officer and Head of Global Policy and Operations, delivered powerful testimony before the UK House of Lords Financial Services Regulation Committee during its inquiry into stablecoin growth and oversight. As one of the world’s largest stablecoin issuers, Circle used the platform to outline a clear vision: the United Kingdom has a historic chance to pioneer a smart, principles-driven regulatory model that secures innovation while protecting financial stability.

Disparte opened by framing the moment as a strategic crossroads. The UK can either set the global standard for digital money or risk importing foreign rules later at the expense of sovereignty and competitiveness.

He reminded lawmakers that stablecoins have already moved from niche tools to the backbone of modern finance.

They now handle trillions in daily settlements, cross-border transfers, corporate treasury operations, and even serve as programmable money for an emerging AI economy.

“You cannot build the economy of tomorrow on yesterday’s rails,” he argued, urging Britain to embrace digital-native money rather than cling to legacy systems.

The executive called for a distinctly British regime—more streamlined than Europe’s MiCA framework yet aligned with the United States’ emerging GENIUS Act.

Core requirements should include full asset reserves, one-to-one redeemability at par value, and rigorous supervision.

Britain’s unique strengths—technology-neutral rules and an outcomes-focused approach—would then be layered on top, creating a model designed for international harmony.

Such a framework, Disparte explained, would draw reputable issuers, empower banks as partners, and reinforce London’s status as a financial hub in a digitised world.

He systematically addressed four common concerns raised in earlier hearings.

First, existing UK payment rails like Faster Payments function well domestically, yet global commerce still suffers from high costs and delays.

Stablecoins can fill that gap with 24/7, programmable settlement without replacing local systems.

Second, fears of deposit flight from banks are misplaced; a well-regulated “multi-money” ecosystem—echoing Bank of England Deputy Governor Sarah Breeden’s vision—would expand credit and intermediation as the digital economy grows.

Third, run risks exist for any form of money but can be neutralised through strict disciplines: high-quality liquid reserves, instant par redemption, and full transparency.

Finally, on illicit finance, Disparte stressed that supervised stablecoins operating on public blockchains actually increase visibility.

Regulated on- and off-ramps, combined with real-time monitoring, give authorities better tools than opaque legacy systems, all while respecting privacy norms.

Circle’s own record lends weight to these arguments.

The firm has processed more than $70 trillion in cumulative transactions worldwide under stringent standards, proving that compliant stablecoins build resilience rather than risk.

Disparte concluded that the UK now faces a binary choice: enact credible rules that attract responsible players and keep economic benefits onshore, or watch activity migrate offshore, importing unseen risks without oversight.

By acting decisively, Britain can strengthen monetary sovereignty, boost competitiveness, and support banks in a multi-currency future.

The Lords’ inquiry represents exactly the leadership moment the UK has seized before—setting standards the world chooses to follow. Circle’s testimony makes one thing clear: with the right framework, stablecoins will not threaten the system; they will supercharge it.

BTQ Technologies has released the first working implementation of Bitcoin Improvement Proposal 360 (BIP 360), marking an early attempt to bring quantum-resistant transaction infrastructure into a live testing environment.

Announced Thursday, the upgrade is now running on the Bitcoin Quantum testnet v0.3.0, a separate blockchain designed to simulate how Bitcoin could function in a post-quantum world. The release moves BIP 360 beyond theory, offering developers, miners, and researchers a place to test quantum-resistant transactions in practice.

BIP 360 introduces a new transaction format known as Pay-to-Merkle-Root (P2MR), which restructures how transaction data is committed on-chain. 

The design removes the need to expose public keys during certain transaction paths, a feature that could become critical if quantum computers advance enough to break current cryptographic protections.

“BIP 360 represents the Bitcoin community’s most significant step toward quantum resistance and we’ve turned it from a proposal into running code,” said Olivier Roussy Newton, CEO of BTQ Technologies, in the company’s press release.

The implementation also preserves key functionality tied to Bitcoin’s scaling roadmap. According to BTQ, P2MR maintains compatibility with scripting features that underpin systems like Lightning and emerging frameworks such as BitVM and Ark, while eliminating the key-path spend mechanism introduced with Taproot that could expose public keys to quantum attacks.

Beyond the core transaction structure, the testnet includes full wallet tooling, allowing users to create, fund, sign, and broadcast P2MR transactions. 

BTQ said this end-to-end functionality makes the upgrade immediately testable, rather than remaining a purely academic proposal.

Bitcoin experimentation and quantum-resistance The company’s broader goal is to accelerate experimentation around quantum-resistant infrastructure at a time when concern over future cryptographic risks is growing. The Bitcoin Quantum testnet currently includes more than 50 miners and has processed over 100,000 blocks, according to the release.

Still, the technical progress highlights a deeper challenge: adoption.

BTQ has effectively bypassed Bitcoin’s traditional governance process by launching its own testing network rather than waiting for consensus within the main ecosystem. That decision reflects longstanding friction around major protocol changes, which historically require broad agreement among developers, miners, and users.

Christopher Tam, BTQ’s head of innovation, framed the issue in human terms. “It’s a social problem,” he told Decrypt, pointing to the difficulty of coordinating change across a decentralized network with entrenched stakeholders.

The approach also raises questions about whether a parallel chain can meaningfully influence Bitcoin’s future. 

Bitcoin Quantum does not share Bitcoin’s ledger or balances, instead launching from a new genesis block with its own asset and ruleset. Users would need to opt in rather than automatically inherit the upgrade.

Even with a working implementation, BIP 360 addresses only part of the quantum threat. Tam noted that while the proposal can help secure future transactions, it does not retroactively protect older addresses that may already have exposed public keys.

The urgency, however, remains. Researchers widely expect that sufficiently advanced quantum computers could eventually break the elliptic-curve cryptography that secures Bitcoin, though the timeline is uncertain.

For now, BTQ’s testnet serves as an early proving ground. Whether its work translates into changes on Bitcoin itself may depend less on code—and more on consensus.

Micah Zimmerman

Micah first discovered Bitcoin in 2018 but remained a skeptic on the sidelines for too long. Since 2021, he has covered crypto and business and now works as a news reporter for Bitcoin Magazine, based in North Carolina.